Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CNI-free Regimen with Everolimus vs Standard CNI in Renal Transplant
NCT00332839Phase 4Terminated
- Sponsor
- Novartis
- Start
- Nov 2005
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in kidney transplant rejection, sponsored by Novartis. Started Nov 2005; status: terminated.
02
Drugs
everolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00332839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332839.